FierceMedicalDevices

FierceMedicalDevices
Share

FierceMedicalDevices

 •  February 9, 2016

Velano Vascular roped in $3.5 million in a round backed by a former Becton Dickinson ($BDX) CEO, adding fuel to the company's fire as it strives to gain market share for its needle-free blood draw device. Previous investors such First Round Capital, White Owl Capital, Kapor Capital and The Children's Hospital of Philadelphia chipped in funding, and...

FierceMedicalDevices

 •  January 26, 2016

SAN FRANCISCO, Jan. 25, 2016 /PRNewswire/ -- entrotech life sciences (ELS) (www.entrotechlifesciences.com) announced it received FDA 510k clearance of ChloraDerm™, the first and only edge-to-edge transparent film dressing to provide The Chlorhexidine Advantage™; a safe, colophony-and acid-free chlorhexidine matrix for wound and catheter site...

FierceMedicalDevices

 •  January 13, 2016

DUBLIN - January 11, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced that the IN.PACT® Admiral® drug eluting balloon (DEB) (also known as the IN.PACT Admiral drug-coated balloon (DCB) in non-European markets) has received CE (Conformité Européene) Mark for arteriovenous (AV) access to...

FierceMedicalDevices

 •  December 2, 2015

Boston Scientific ($BSX) announced simultaneous approval to market its AngioJet ZelanteDVT thrombectomy catheter for treating deep vein

FierceMedicalDevices

 •  July 10, 2015

Catheters designed to deliver chemotherapy are often coated in silver to provide an antibacterial coating. But scientists at the Norwegian University of Science and Technology found that this silver actually breaks down chemotherapy drugs and can release a harmful gas, hydrogen fluoride in the process. The researchers expect that graphene, which ...